Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT00274924 · COMPLETED
Trial details
- NCT number
- NCT00274924
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-26
- Primary completion
- 2013-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.